EGFR and breast carcinoma: More recently, the extracellular domain of soluble E-cadherin was shown to interact with EGFR and activate EGFR-mediated PI3K/AKT and ERK1/2 signalling in breast cancer cells and squamous cell carcinoma [29,30].